SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001016169-05-000024
Filing Date
2005-08-24
Accepted
2005-08-24 14:05:01
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ka10-2004.htm 10-K/A 1087163
2 GRAPHIC tplatforms.gif GRAPHIC 9172
3 ex21-1.htm EX-21 1443
4 ex23-1.htm EX-23 2391
5 ex31-1.htm EX-31 7524
6 ex31-2.htm EX-31 7579
7 ex32.htm EX-32 3577
  Complete submission text file 0001016169-05-000024.txt   1124105
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32302 | Film No.: 051045659
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10